Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507440 · ClinicalTrials.gov registry record · Phase 4
Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's
A Phase 4 study of Topical Anesthesia, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02507440 is a Phase 4 study of Topical Anesthesia that has completed, run by Bassett Healthcare. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02507440, a Phase 4 study of Topical Anesthesia, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To find out if the administration of the local pharyngeal anesthetic, lidocaine, in conjunction with Propofol during elective Esophagogastroduodenoscopy (EGD) is useful, safe and impacts the time of discharge of patient compared to placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lidocaine
- DRUG Propofol
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02507440
The ClinicalTrials.gov registry entry for NCT02507440 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Topical Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02507440 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02507440 about?
NCT02507440 is a clinical study titled "Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's". To find out if the administration of the local pharyngeal anesthetic, lidocaine, in conjunction with Propofol during elective Esophagogastroduodenoscopy (EGD) is useful, safe and impacts the time of discharge of patient compared to placebo.
What is the current status of trial NCT02507440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2015-09. Estimated completion is 2016-11.
What conditions does trial NCT02507440 study?
This clinical trial studies the following conditions: Topical Anesthesia.
What interventions are being tested in trial NCT02507440?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT02507440?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02507440 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.